Featured Articles
-
Genomic Medicine And The Tools To Realize Its Potential
1/12/2022
New technologies and collaborations driving the democratization of RNA therapeutics are creating an explosion of opportunity for companies pursuing the development of these transformative medicines.
-
Key Insights Into Overcoming mRNA Process Challenges
9/8/2021
Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.
-
mRNA Manufacturing Workflow
6/2/2021
Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.
-
Intensified Chromatography Strategies
7/26/2019
With a newer toolbox of options to intensify downstream manufacturing operations, it is important to understand what factors should impact decisions regarding the implementation of these solutions.
-
Designing Agile Manufacturing With An Integrated Drug Product Ecosystem
Companies aiming to accelerate biomanufacturing operations and use resources efficiently need access to technologies that can safely and efficiently complete their workflow from discovery to delivery.
-
Research And Industry Join Forces As Modalities Merge
How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.
-
Standardization And Flexibility In Aseptic Filling
Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?
-
Add mRNA Capacity — Flexibly
Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.
-
Oligonucleotide Manufacturing: Take Control Of Your Process
What do you need to know before you take your process in-house? A team of experts on nucleic acids therapeutics outlined five key things for you to consider as you make the change.